Chapter 10 M-T7. Measuring Chemokine-Modulating Activity

Methods in Enzymology

Volumn 460, Issue A, 2009, Pages 209-228

  Bartee, Mee Y ^a,b   Dai, Erbin ^b   Liu, Liying ^b   Munuswamy Ramanujam, Ganesh ^a,b   Macaulay, Colin ^a   McIvor, Dana ^a   McFadden, Grant ^b   Lucas, Alexandra R ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; GLYCOSAMINOGLYCAN; M T7 PROTEIN; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ATHEROSCLEROSIS; AORTA GRAFT; ASCITES; CELL ADHESION; CONTROLLED STUDY; EX VIVO STUDY; GENE IDENTIFICATION; IN VITRO STUDY; INFLAMMATION; INFLAMMATORY CELL; MEMBRANE FLUIDITY; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PURIFICATION; REVIEW; STAINING; STATISTICS; VASCULAR DISEASE; VASCULITIS; ANIMAL; ARTICLE; CELL LINE; CELL MOTION; DRUG EFFECT; HUMAN; METABOLISM; MONOCYTE; MYXOMA VIRUS; PROTEIN BINDING; RABBIT; RAT;

MYXOMA VIRUS; RODENTIA;

ANIMALS; CELL ADHESION; CELL LINE; CELL MOVEMENT; CHEMOKINES; HUMANS; MEMBRANE FLUIDITY; MICE; MONOCYTES; MYXOMA VIRUS; PROTEIN BINDING; RABBITS; RATS; VIRAL PROTEINS;

EID: 65549159197     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(09)05210-0     Document Type: Review

References (20)

1. Allen S.J., Crown S.E., and Handel T.M. Chemokine: Receptor structure, interactions, and antagonism. Annu. Rev. Immunol. 25 (2007) 787-820
2. Arnold K., Bordoli L., Kopp J., and Schwede T. The SWISS-MODEL workspace: A web-based environment for protein structure homology modelling. Bioinformatics 22 (2006) 195-201
3. Bedard E.L., Kim P., Jiang J., Parry N., Liu L., Wang H., Garcia B., Li X., McFadden G., Lucas A., and Zhong R. Chemokine-binding viral protein M-T7 prevents chronic rejection in rat renal allografts. Transplantation 76 (2003) 249-252
4. Forsberg E., and Kjellen L. Heparan sulfate: Lessons from knockout mice. J. Clin. Invest. 108 (2001) 175-180
5. Handel T.M., Johnson Z., Crown S.E., Lau E.K., and Proudfoot A.E. Regulation of protein function by glycosaminoglycans-as exemplified by chemokines. Annu. Rev. Biochem. 74 (2005) 385-410
6. Johnson Z., Kosco-Vilbois M.H., Herren S., Cirillo R., Muzio V., Zaratin P., Carbonatto M., Mack M., Smailbegovic A., Rose M., Lever R., Page C., et al. Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system. J. Immunol. 173 (2004) 5776-5785
7. Johnson Z., Power C.A., Weiss C., Rintelen F., Ji H., Ruckle T., Camps M., Wells T.N., Schwarz M.K., Proudfoot A.E., and Rommel C. Chemokine inhibition-Why, when, where, which and how?. Biochem. Soc. Trans. 32 (2004) 366-377
8. Kopp J., and Schwede T. The SWISS-MODEL repository of annotated three-dimensional protein structure homology models. Nucleic Acids Res. 32 (2004) D230-D234
9. Lalani A.S., Ness T.L., Singh R., Harrison J.K., Seet B.T., Kelvin D.J., McFadden G., and Moyer R.W. Functional comparisons among members of the poxvirus T1/35kDa family of soluble CC-chemokine inhibitor glycoproteins. Virology 250 (1998) 173-184
10. Liu L., Dai E., Miller L., Seet B., Lalani A., Macauley C., Li X., Virgin H.W., Bunce C., Turner P., Moyer R., McFadden G., and Lucas A. Viral chemokine-binding proteins inhibit inflammatory responses and aortic allograft transplant vasculopathy in rat models. Transplantation 77 (2004) 1652-1660
11. Liu L., Lalani A., Dai E., Seet B., Macauley C., Singh R., Fan L., McFadden G., and Lucas A. The viral anti-inflammatory chemokine-binding protein M-T7 reduces intimal hyperplasia after vascular injury. J. Clin. Invest. 105 (2000) 1613-1621
12. Mossman K., Nation P., Macen J., Garbutt M., Lucas A., and McFadden G. Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. Virology 215 (1996) 17-30
13. Mossman K., Upton C., and McFadden G. The myxoma virus-soluble interferon-gamma receptor homolog, M-T7, inhibits interferon-gamma in a species-specific manner. J. Biol. Chem. 270 (1995) 3031-3038
14. Parish C.R. Heparan sulfate and inflammation. Nat. Immunol. 6 (2005) 861-862
15. Proudfoot A.E., Power C.A., Rommel C., and Wells T.N. Strategies for chemokine antagonists as therapeutics. Semin. Immunol. 15 (2003) 57-65
16. Seet B.T., Singh R., Paavola C., Lau E.K., Handel T.M., and McFadden G. Molecular determinants for CC-chemokine recognition by a poxvirus CC-chemokine inhibitor. Proc. Natl. Acad. Sci. USA 98 (2001) 9008-9013
17. Serabian M.A., and Pilaro A.M. Safety assessment of biotechnology-derived pharmaceuticals: ICH and beyond. Toxicol. Pathol. 27 (1999) 27-31
18. Tolner B., Smith L., Hillyer T., Bhatia J., Beckett P., Robson L., Sharma S.K., Griffin N., Vervecken W., Contreras R., Pedley R.B., Begent R.H., et al. From laboratory to Phase I/II cancer trials with recombinant biotherapeutics. Eur. J. Cancer 43 (2007) 2515-2522
19. Upton C., Mossman K., and McFadden G. Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science 258 (1992) 1369-1372
20. Weber C., Schober A., and Zernecke A. Chemokines: Key regulators of mononuclear cell recruitment in atherosclerotic vascular disease. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1997-2008